Nymox Pharmaceutical Corporation
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $3.1M | $712.0K | $374.0K |
| FY2016 | $2.3M | $2.1M | $2.0M |
| FY2017 | $2.2M | $979.0K | $851.0K |
| FY2018 | $1.1M | $8.1M | $7.9M |
| FY2019 | $2.0M | $5.5M | $5.2M |
| FY2020 | $2.2M | $4.3M | $3.6M |
| FY2021 | $1.9M | $1.4M | $830.0K |
| FY2022 | $2.1M | $1.6M | — |
| FY2023 | $3.8M | $627.0K | — |
| FY2024 | $7.4M | $654.0K | — |